CRL
Charles River Laboratories International, Inc. β’ Healthcare (#8 of 11)
$185.00
+2.66 (+1.46%)
View:
Close:$185.00
Vol:EXTREME(95%ile)
Ratio:1.58x
|RSI:57(Neutral)
MACD:β
β₯75%25-75%<25%
Vol.%
Sector Rotation
2026-06-18(10/10)
20d Strength (bar)
Strong (Β±4%)
Normal (-2~+3%)
5d Strength (normal: -1~+1%)
Relative Strength Trajectory
5d Strength
10d Strength
20d Strength
NASDAQ
10d early: 3~5%|20d confirm: 4~8.5%|>8.5% exhaustion
Analyst Actions
NEUTRALβ²2 UpβΌ0 Down0 Hold
Jun 17Morgan Stanley
β²Equal-Weight β Overweight
May 29CLSA
β²Hold β Outperform
Price Targets
β²2 RaisesβΌ0 Lowers+25.0% avg
Jun 17Morgan Stanley
$185β$220+18.9%
May 29CLSA
$167β$219+31.1%
Trade Setup
ATR-basedEntry$185.00
Target$200.26 (+8.3%)
Stop$173.55
R/R1.33
Risk-6.2%
ATR$7.63
Simple setup: 1.5x ATR stop, 2x ATR target
Risk Metrics
Sharpe (20d)
4.55Excellent
Volatility (20d)
49.9%High
Beta (60d)
1.38Aggressive
Alpha (20d)
+17.6%Strong
News Analysis
EN
δΈ
ν
ζ₯
No analysis record found.